DOCSLIB.ORG

Liquiplastin ®

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Liquiplastin ® EN ISO 13485:2012 Performance Evaluations LIQUIPLASTIN ® Thromboplastin for PT determination Performance Evaluations EN ISO 13485:2012 INDEX S. No. Name of the Publication Pg Nos 1. British Journal of Clinical Pharmacology/65:5/2008 787 - 790 2. The European e- Journal of Clinical Nutrition and Metabolism (2008) 1-8 3. World Journal of Pharmaceutical Sciences 2016; 4(10) 50-56 4. International Journal of Nutrition, Pharmacology, Neurological Diseases | July-September 2016 | Vol 6 | Issue 3 101-110 5. Journal of Evolution of Medical and Dental Sciences/ Volume 2/ Issue 2/ January 14, 2013 72-78 6. International Journal of Research in Ayurveda & Pharmacy , 1(2), Nov-Dec 2010 586-589 7. Journal of Applied Pharmaceutical Science Vol. 7 (03), March, 2017 081-087 8. International Journal of Pharmacy and Pharmaceutical Sciences, Vol 7, Supple 1, 104-111 9. Journal of Chemical and Pharmaceutical Research, 2015, 7(5) 973-980 10. International Journal of Scientific Study | August 2016 | Vol 4 | Issue 5 216-221 11. International Journal of Current Research in Biosciences and Plant Biology, Vol 3 February 2016 106-113 12. International Journal of Pharma and Biosciences, 2014 July, (5)3 705-709 LIQUIPLASTIN ® Thromboplastin for PT determination British Journal of Clinical DOI:10.1111/j.1365-2125.2008.03113.x Pharmacology Correspondence Dr Nithya Gogtay, Department of Clinical A pilot study of the Pharmacology, New MS Building, 1st Floor, Seth GS Medical College and KEM Hospital, Parel, Mumbai 400012, India. association of Tel.: +91 22 2413 3767/2417 4420 Fax: +91 22 2411 2871 pharmacokinetic and E-mail: [email protected] ---------------------------------------------------------------------- *UPK was partly supported by the Short-term studentship programme 2006 pharmacodynamic of the Indian Council of Medical Research, New Delhi. parameters of warfarin with ---------------------------------------------------------------------- Keywords international normalized ratio, warfarin the dose in patients on ---------------------------------------------------------------------- Received 20 April 2007 long-term anticoagulation Accepted 3 January 2008 Uday P. Kulkarni,1* Balkrishna D. Swar,1 Dilip R. Karnad,2 Published OnlineEarly 21 February 2008 Sanish Davis,1 Anil M. Patwardhan,3 Nilima A. Kshirsagar1 & Nithya J. Gogtay1 Departments of 1Clinical Pharmacology, 2Medicine and 3Cardiovascular and Thoracic Surgery, Seth GS Medical College and KEM Hospital, Parel, Mumbai 400012, India WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Warfarin is a widely used anticoagulant with a low therapeutic index. AIMS • There is wide interindividual variation in the To assess the correlation between plasma total warfarin concentration, pharmacokinetics and pharmacodynamics plasma 7-hydroxywarfarin concentration and INR and the weekly doses of warfarin which is also reflected in the of warfarin in patients on long-term anticoagulation. warfarin dose requirement. METHODS • CYP2C9 and VKORC1 polymorphisms have Twenty-five patients on long-term anticoagulation with warfarin were been shown to affect warfarin dose studied. Plasma total warfarin and 7-hydroxywarfarin concentrations requirement. However a large amount of the and INR were determined. Equations were derived with the weekly variation in warfarin dose remains warfarin dose as the dependent variable and plasma total warfarin unaccounted for. concentration : plasma 7-hydroxywarfarin concentration, INR : plasma total warfarin concentration and INR : plasma 7-hydroxywarfarin concentration as independent variables. WHAT THIS STUDY ADDS RESULTS There was a good correlation between INR : plasma total warfarin • Our findings suggest that in patients who concentration and the weekly dose of warfarin (y = 46.73e-0.30x, are on long-term warfarin therapy, r2 = 0.65). There was a better correlation between INR : plasma INR : plasma 7-hydroxywarfarin 7-hydroxywarfarin concentration and the weekly dose of warfarin concentration correlates well with warfarin (y = 156.52x-0.63, r2 = 0.74) requirement and also accounts for a large CONCLUSIONS amount of variation in warfarin dose. Pharmacokinetic parameters along with INR seem to correlate with the weekly doses of warfarin in patients on long-term anticoagulation. These parameters may therefore be useful for predicting warfarin doses. © 2008 The Authors Br J Clin Pharmacol / 65:5 / 787–790 / 787 Journal compilation © 2008 Blackwell Publishing Ltd U. P.Kulkarni et al. Introduction centration : plasma 7-hydroxywarfarin concentration, INR : plasma total warfarin concentration and INR : plasma Warfarin is a widely used anticoagulant with a low thera- 7-hydroxywarfarin concentration as independent vari- peutic index. There is wide interindividual variation in the ables. The third INR value was used for deriving the pharmacokinetics and pharmacodynamics of warfarin. equations. Polymorphisms of CYP2C9 and VKORC1 have been shown to affect warfarin dose requirement. Previous studies have evaluated the utility of genotyping for CYP2C9 and Results VKORC1 in predicting warfarin dose in patients on long- term anticoagulation, but have found that these geno- The mean age of the patients (18 males and seven females) types account for only about 60% of variation in dose [1]. was 37.28 Ϯ 10.23 (SD) years (range 22–56 years).The indi- Hence genotyping for CYP2C9 and VKORC1 is not used cation for warfarin therapy was mitral valve replacement currently for optimizing warfarin therapy. Many factors (n = 8), deep vein thrombosis (n = 6), aortic valve replace- other than CYP2C9 and VKORC1 polymorphisms also affect ment (n = 3), aortic and mitral valve replacement (n = 3), warfarin requirement including polymorphisms in other atrial fibrillation (n = 2), venous sinus thrombosis (n = 2) genes, concomitant drug intake, ethnicity and vitamin K and arterial embolism (n = 1). The mean weekly dose content of the diet [2]. Therefore, models for prediction of of warfarin was 34.58 Ϯ 14.76 (SD) mg (range warfarin doses using parameters other than gene poly- 7–70 mg week-1). The mean INR at recruitment was morphisms are necessary. Hence the present study was 2.20 Ϯ 0.67 (SD) (range 1.3–3.7). The mean total warfarin undertaken to assess the correlation between plasma total concentration was 3.01 Ϯ 2.48 (SD) mgml-1. The mean warfarin concentration,plasma 7-hydroxywarfarin concen- 7-hydroxy warfarin concentration was 0.20 Ϯ 0.13 (SD) tration and INR and the weekly dose of warfarin in patients mgml-1. on long-term anticoagulation. There was an extremely poor correlation between the plasma total warfarin : plasma 7-hydroxywarfarin ratio and the weekly dose of warfarin (y = 26.67e0.01x, r2 = 0.02).There Methods was a better correlation between INR : plasma total war- farin concentration and the weekly dose of warfarin Twenty-five patients on long-term warfarin therapy were (y = 46.73e-0.30x, r2 = 0.65) (Figure 1). There was a good cor- studied as per a protocol approved by the Institutional relation between INR : plasma 7-hydroxywarfarin concen- Ethics Committee, after obtaining written informed tration and the weekly dose of warfarin (y = 156.52x-0.63, consent. At screening, two INR measurements 15 days r2 = 0.74) (Figure 2). apart were done. If these were within the therapeutic The concomitant drugs taken by patients during the range without any change in the dose, then the patient study were furosemide (6), diltiazem (3), digoxin (3), KCl (3), was eligible for recruitment to the study. As per the treat- aspirin (2),salbutamol (1),enalapril (1),pentoxyphylline (1), ment protocol followed in the hospital,the target range for vitamin B complex (1), amlodipine (1), phenytoin (1), ben- INR was between 2 and 3 for all indications except for zathine penicillin (1), folic acid (1), spironolactone (1) and patients with prosthetic mitral valves where the range was chlorpromazine (1). In the patient receiving phenytoin, the 2.5–3.5.Venous blood (7 ml) was collected from all patients 12 h after the last dose of warfarin.This sample was used to perform a third INR as well as estimate the concentration INR/W v/s weekly dose of warfarin (N = 25) of total warfarin and 7-hydroxywarfarin by high perfor- 80 mance liquid chromatography (HPLC) using a C-18 70 column.Briefly,isopropanol with phosphate buffer was the 60 –0.30x mobile phase, flow rate was 1 ml min-1, pressure range up 50 y = 46.73e r2 = 0.65 to 5000 psi, and wavelength (l) of the UV lamp was as 40 308 nm at 30°C. The standard concentrations for the drug 30 and metabolite were 0.05,0.1,0.5,1.0,2.5 and 5 mgml-1.The 20 assay was linear in the range of 0.05–5.0 mgml-1.The inter- 10 day coefficient of variation was between 8.75% and 0 12.85%. The intraday coefficient of variation was between (mg) warfarin of dose Weekly 01234567 4.23% and 7.14%. Carbamazepine was used as an internal INR/W standard. PT-INR (prothrombin time-International Normal- ized Ratio) was determined using the Liquiplastin reagent Figure 1 obtained from Tulip Diagnostics (P) Ltd, Goa, India. Equa- INR : plasma total warfarin concentration vs. weekly dose of warfarin tions were derived with the weekly warfarin dose as (n = 25). INR = International Normalized Ratio; W = Plasma warfarin con- the dependent variable and plasma total warfarin con- centration (mgml-1) 788 / 65:5 / Br J Clin Pharmacol Short report INR/M v/s weekly dose of warfarin (N = 25) dynamic index of warfarin and found that the warfarin 80 dose correlated well with the INR : plasma total warfarin -0.30x 2 70 ratio (y = 46.73e , r = 0.65). –0.63 60 y = 156.52x The dose of warfarin required to achieve adequate anti- r2 = 0.74 50 coagulation would be lower in patients with a higher 40 metabolic ratio as well as those with a higher INR : plasma 30 total warfarin concentration ratio. Thus both INR : plasma 20 total warfarin concentration ratio and the metabolic ratio 10 would have an inverse relationship with the dose. To sim- 0 plify things, we combined the pharmacodynamic index Weekly dose of warfarin (mg) warfarin of dose Weekly 0 102030405060708090100 and the metabolic ratio: INR/M Equation 1 Warfarin dose=× K11( INR : plasma total warfarin Figure 2 concentration) or INR : plasma total 7-hydroxywarfarin concentration vs.
Load more

Recommended publications
  • Medicinal Practices of Sacred Natural Sites: a Socio-Religious Approach for Successful Implementation of Primary
    Medicinal practices of sacred natural sites: a socio-religious approach for successful implementation of primary healthcare services Rajasri Ray and Avik Ray Review Correspondence Abstract Rajasri Ray*, Avik Ray Centre for studies in Ethnobiology, Biodiversity and Background: Sacred groves are model systems that Sustainability (CEiBa), Malda - 732103, West have the potential to contribute to rural healthcare Bengal, India owing to their medicinal floral diversity and strong social acceptance. *Corresponding Author: Rajasri Ray; [email protected] Methods: We examined this idea employing ethnomedicinal plants and their application Ethnobotany Research & Applications documented from sacred groves across India. A total 20:34 (2020) of 65 published documents were shortlisted for the Key words: AYUSH; Ethnomedicine; Medicinal plant; preparation of database and statistical analysis. Sacred grove; Spatial fidelity; Tropical diseases Standard ethnobotanical indices and mapping were used to capture the current trend. Background Results: A total of 1247 species from 152 families Human-nature interaction has been long entwined in has been documented for use against eighteen the history of humanity. Apart from deriving natural categories of diseases common in tropical and sub- resources, humans have a deep rooted tradition of tropical landscapes. Though the reported species venerating nature which is extensively observed are clustered around a few widely distributed across continents (Verschuuren 2010). The tradition families, 71% of them are uniquely represented from has attracted attention of researchers and policy- any single biogeographic region. The use of multiple makers for its impact on local ecological and socio- species in treating an ailment, high use value of the economic dynamics. Ethnomedicine that emanated popular plants, and cross-community similarity in from this tradition, deals health issues with nature- disease treatment reflects rich community wisdom to derived resources.
    [Show full text]
  • TFG QU Gonzalez Fernandez, Nuria.Pdf
    Tutor/s Dra. Elisabet Fuguet Jordà Departament d’Enginyeria Química i Química Analítica Dr. Fermin Huarte Larrañaga Departament de Ciència dels Materials i Química Física Treball Final de Grau Gender perspective in the subjects of the Chemistry Degree of the University of Barcelona: contribution of women to the curriculum of the Degree. Perspectiva de gènere en les assignatures del Grau de Química de la Universitat de Barcelona: contribucions de científiques en els continguts del Grau. Núria González Fernández June 2021 Aquesta obra està subjecta a la llicència de: Reconeixement–NoComercial-SenseObraDerivada http://creativecommons.org/licenses/by-nc-nd/3.0/es/ Courage is like a habit, a virtue: you get it by courageous acts. It’s like you learn to swim by swimming. You learn courage by couraging. Marie Maynard Daly Vull agrair a tots els docents que, al llarg de la carrera, m’han fet sentir part de la ciència i han col·laborat al desenvolupament del meu sentit de la curiositat. M’han format com a professional però també com a persona amb esperit crític. En especial a la meva tutora Elisabet i al meu tutor Fermin, que m’han fet creure en aquest treball i en la importància del mateix, gràcies per oferir la possibilitat d’acabar el grau de la manera més satisfactòria. També a la meva família, que m’ha acompanyat durant tots els anys de formació i especialment ara. Finalment dedicar aquest treball en definitiva a totes les dones que m’envolten, amigues, professores, àvies i mare, gràcies per ser referents. REPORT Gender perspective in the subjects of the Chemistry Degree… 1 CONTENTS 1.
    [Show full text]
  • Dictionary of Cultivated Plants and Their Regions of Diversity Second Edition Revised Of: A.C
    Dictionary of cultivated plants and their regions of diversity Second edition revised of: A.C. Zeven and P.M. Zhukovsky, 1975, Dictionary of cultivated plants and their centres of diversity 'N -'\:K 1~ Li Dictionary of cultivated plants and their regions of diversity Excluding most ornamentals, forest trees and lower plants A.C. Zeven andJ.M.J, de Wet K pudoc Centre for Agricultural Publishing and Documentation Wageningen - 1982 ~T—^/-/- /+<>?- •/ CIP-GEGEVENS Zeven, A.C. Dictionary ofcultivate d plants andthei rregion so f diversity: excluding mostornamentals ,fores t treesan d lowerplant s/ A.C .Zeve n andJ.M.J ,d eWet .- Wageninge n : Pudoc. -11 1 Herz,uitg . van:Dictionar y of cultivatedplant s andthei r centreso fdiversit y /A.C .Zeve n andP.M . Zhukovsky, 1975.- Me t index,lit .opg . ISBN 90-220-0785-5 SISO63 2UD C63 3 Trefw.:plantenteelt . ISBN 90-220-0785-5 ©Centre forAgricultura l Publishing and Documentation, Wageningen,1982 . Nopar t of thisboo k mayb e reproduced andpublishe d in any form,b y print, photoprint,microfil m or any othermean swithou t written permission from thepublisher . Contents Preface 7 History of thewor k 8 Origins of agriculture anddomesticatio n ofplant s Cradles of agriculture and regions of diversity 21 1 Chinese-Japanese Region 32 2 Indochinese-IndonesianRegio n 48 3 Australian Region 65 4 Hindustani Region 70 5 Central AsianRegio n 81 6 NearEaster n Region 87 7 Mediterranean Region 103 8 African Region 121 9 European-Siberian Region 148 10 South American Region 164 11 CentralAmerica n andMexica n Region 185 12 NorthAmerica n Region 199 Specieswithou t an identified region 207 References 209 Indexo fbotanica l names 228 Preface The aimo f thiswor k ist ogiv e thereade r quick reference toth e regionso f diversity ofcultivate d plants.Fo r important crops,region so fdiversit y of related wild species areals opresented .Wil d species areofte nusefu l sources of genes to improve thevalu eo fcrops .
    [Show full text]
  • Developmental Studies on Novel Biodegradable Polyester Films from Maravetti Oil
    J. Environ. Nanotechnol. Volume 8, No. 4 pp. 01-07 ISSN (Print): 2279-0748 ISSN (Online): 2319-5541 doi:10.13074/jent.2019.12.194379 Developmental Studies on Novel Biodegradable Polyester Films from Maravetti Oil T. Sahaya Maria Jeyaseeli1, I. Antony Danish2, J. Shakina1* 1Department of Chemistry, Sarah Tucker College (Autonomous), Tirunelveli, TN, India. 2Department of Chemistry, Sadakathullah Appa College (Autonomous), Tirunelveli, TN, India. Abstract Novel biodegradable polyester film was synthesised from naturally available Maravetti oil, formic acid and 30% hydrogen peroxide by stepwise polymerisation technique. The polymer was prepared by resin react with styrene. The UV, FTIR and NMR spectral studies carried out to identify the nature of the polymer formed. SEM analysis confirmed that the polymer was biodegradable in nature. The biodegradability of the polyester film was studied by soil burial test. The thermal degradation at different time intervals were analysed by TG-DTA analysis. The cross- linking ability of the polymers was checked by DSC analysis. Mechanical properties like tensile strength and impact strength were characterized. The resulted polymers have satisfied mechanical performance and fast curing speed. Keywords: Cross-linking; Degradation; Polymer Soil Burial; Styrene. 1. INTRODUCTION peroxide (30%) (Rankem) were used in the first step functionalization. Maleic acid (Rankem) and In our world over 6.3 billion plastics are Morpholine (Rankem). Benzoyl peroxide (Rankem) generated, only 9% is recycled, 12% incinerated, 79% was used as a radical initiator and N, N-Dimethyl accumulated in natural environment. In the production aniline (Rankem) was used as accelerator in the curing of plastics, monomers used which are derived from process.
    [Show full text]
  • India Report On
    AG:GCP/RAS/186/JPN Field Document No.2006/03 FAO/GOVERNMENT COOPERATIVE PROGRAM Report on the Establishment of the National Information Sharing Mechanism on the Implementation of the Global Plan of Action for the Conservation and Sustainable Utilization of Plant Genetic Resources for Food and Agriculture in India Compiled by R.C. Agrawal Pratibha Brahmi Sanjeev Saxena Gurinder Jit Randhawa Kavita Gupta D.S. Mishra J.L. Karihaloo 2006 DEPARTMENT OF AGRICULTURE AND COOPERATION Ministry of Agriculture, Krishi Bhawan New Delhi-110 001, INDIA and NATIONAL BUREAU OF PLANT GENETIC RESOURCES (Indian Council of Agricultural Research) Pusa Campus, New Delhi-110 012, INDIA The designation and presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Food and Agriculture Organization of the United Nations and National Bureau of Plant Genetic Resources/ Indian Council of Agricultural Research/Department of Agriculture and Co-operation concerning the legal status of any country, territory, city or area of its authorities or concerning the delimitation of its frontiers and boundaries. Published by: Director National Bureau of Plant Genetic Resources Pusa Campus, New Delhi - 110 012, India (on behalf of Department of Agriculture and Cooperation, Ministry of Agriculture, Government of India) Citation: Agrawal R.C., Brahmi Pratibha, Saxena Sanjeev, Randhawa Gurinder Jit, Gupta Kavita, Mishra D.S and Karihaloo J.L. (2006). Report on Establishment of the National Information Sharing Mechanism on the Implementation of the Global Plan of Action for the Conservation and Sustainable Utilization of Plant Genetic Resources for Food and Agriculture in India.
    [Show full text]
  • Intoduction to Ethnobotany
    Intoduction to Ethnobotany The diversity of plants and plant uses Draft, version November 22, 2018 Shipunov, Alexey (compiler). Introduction to Ethnobotany. The diversity of plant uses. November 22, 2018 version (draft). 358 pp. At the moment, this is based largely on P. Zhukovskij’s “Cultivated plants and their wild relatives” (1950, 1961), and A.C.Zeven & J.M.J. de Wet “Dictionary of cultivated plants and their regions of diversity” (1982). Title page image: Mandragora officinarum (Solanaceae), “female” mandrake, from “Hortus sanitatis” (1491). This work is dedicated to public domain. Contents Cultivated plants and their wild relatives 4 Dictionary of cultivated plants and their regions of diversity 92 Cultivated plants and their wild relatives 4 5 CEREALS AND OTHER STARCH PLANTS Wheat It is pointed out that the wild species of Triticum and rela­ted genera are found in arid areas; the greatest concentration of them is in the Soviet republics of Georgia and Armenia and these are regarded as their centre of origin. A table is given show- ing the geographical distribution of 20 species of Triticum, 3 diploid, 10 tetraploid and 7 hexaploid, six of the species are endemic in Georgia and Armenia: the diploid T. urarthu, the tetraploids T. timopheevi, T. palaeo-colchicum, T. chaldicum and T. carthlicum and the hexaploid T. macha, Transcaucasia is also considered to be the place of origin of T. vulgare. The 20 species are described in turn; they comprise 4 wild species, T. aegilopoides, T. urarthu (2n = 14), T. dicoccoides and T. chaldicum (2n = 28) and 16 cultivated species. A number of synonyms are indicated for most of the species.
    [Show full text]
  • The Military and Hospitaller Order of Saint Lazarus of Jerusalem
    The Military and Hospitaller Order of Saint Lazarus of Jerusalem INTERNATIONAL HOSPITALLER REPORT 2014 Thanks to: All contributors to charity and hospitaller activities Hospitaller Working Group PRC Committee Jurisdictions, Grand and Hereditary Commanderies Vice Grand Chancellor Administration Grand Commander The Military and Hospitaller Order of Saint Lazarus of Jerusalem 2 of 70 International Hospitaller Report 2014 Table of Contents Page 1. Table of Contents 2 2. Jurisdictions of the Order 3 3. Address by the Grand Master 5 4. Address by the Grand Commander 6 5. Introduction by the Grand Hospitaller 7 6. Foreword 8 7. General Overview 10 8. Leprosy and Tuberculosis 11 8.1 Leprosy History 11 8.1.2 Why is leprosy called Hansen’s disease 12 8.1.3 Leprosy today 12 8.1.4 Europe’s last Leper Colony 13 8.1.5 Leprosy is a great lady 14 8.1.6 Key facts of Leprosy (WHO) 15 8.1.7 Multidrug therapy 15 8.2 Tuberculosis 16 8.2.1 Mycobacterium-leprae and Mycobacterium-tuberculosis 17 8.2.2 Tuberculosis in our modern Society 17 9. Contribution of our Order in the Battle against Leprosy 18 10. Hospice and Palliative Care 26 11. Contribution of our Order in the field of Hospice and Palliative Care 28 11.1 One of the projects “the Saint Louis Hospital in Jerusalem” 34 12. Care for Children 36 13. Support of Handicapped People 49 14. Food Campaigns 51 15. Organ Transplants 53 16. Community Service 55 17. Miscellaneous, not classified 67 18. Atavis et Armis 70 International Hospitaller Report 2014 final – rectification 2016 02 03 2 of 70 The Military and Hospitaller Order of Saint Lazarus of Jerusalem 3 of 70 International Hospitaller Report 2014 2.
    [Show full text]
  • Phytosociological Studies of the Sacred Grove of Kanyakumari District, Tamilnadu, India
    ISSN (E): 2349 – 1183 ISSN (P): 2349 – 9265 5(1): 29–40, 2018 DOI: 10.22271/tpr.201 8.v5.i1 .006 Research article Phytosociological studies of the sacred grove of Kanyakumari district, Tamilnadu, India S. Sukumaran1*, A. Pepsi1, D. S. SivaPradesh1 and S. Jeeva2 1Department of Botany and Research centre, Nesamony Memorial Christian College, Marthandam, Kanyakumari-629165, Tamilnadu, India 2Department of Botany and Research centre, Scott Christian College, Nagercoil, Kanyakumari-629003, Tamilnadu, India *Corresponding Author: [email protected] [Accepted: 28 March 2018] Abstract: Sacred groves are forest patches conserved by the local people through religious and cultural practices. These groves are important reservoirs of biodiversity, preserving indigenous plant species and serving as asylum of Rare, Endangered and Threatened (RET) species. The present study was carried out in Muppuram coastal sacred grove of Kanyakumari district to reveal the plant diversity, structure and regeneration pattern of trees using quadrate method. About 102 plant species were recorded from the total area (0.2 ha) of the grove studied. The vegetation of the grove clearly indicates tropical dry evergreen forest. Malvaceae was the dominant family. Young plant species were dominating than older ones (> 160 cm). To avoid the rapid environmental degradation of the sacred grove, conserving the groves is urgent and it is necessary to conduct more researches on this grove as well as other groves of the district. Keywords: Floristic diversity - Regeneration - Conservation - Sacred groves - Traditional. [Cite as: Sukumaran S, Pepsi A, SivaPradesh DS & Jeeva S (2018) Phytosociological studies of the sacred grove of Kanyakumari district, Tamilnadu, India. Tropical Plant Research 5(1): 29–40] INTRODUCTION The degradation of tropical forests and destruction of habitat due to anthropogenic activities are the major causes of the decline in global biodiversity (Sukumaran et al.
    [Show full text]
  • Larval Host Plants of the Butterflies of the Western Ghats, India
    OPEN ACCESS The Journal of Threatened Taxa is dedicated to building evidence for conservaton globally by publishing peer-reviewed artcles online every month at a reasonably rapid rate at www.threatenedtaxa.org. All artcles published in JoTT are registered under Creatve Commons Atributon 4.0 Internatonal License unless otherwise mentoned. JoTT allows unrestricted use of artcles in any medium, reproducton, and distributon by providing adequate credit to the authors and the source of publicaton. Journal of Threatened Taxa Building evidence for conservaton globally www.threatenedtaxa.org ISSN 0974-7907 (Online) | ISSN 0974-7893 (Print) Monograph Larval host plants of the butterflies of the Western Ghats, India Ravikanthachari Nitn, V.C. Balakrishnan, Paresh V. Churi, S. Kalesh, Satya Prakash & Krushnamegh Kunte 10 April 2018 | Vol. 10 | No. 4 | Pages: 11495–11550 10.11609/jot.3104.10.4.11495-11550 For Focus, Scope, Aims, Policies and Guidelines visit htp://threatenedtaxa.org/index.php/JoTT/about/editorialPolicies#custom-0 For Artcle Submission Guidelines visit htp://threatenedtaxa.org/index.php/JoTT/about/submissions#onlineSubmissions For Policies against Scientfc Misconduct visit htp://threatenedtaxa.org/index.php/JoTT/about/editorialPolicies#custom-2 For reprints contact <[email protected]> Threatened Taxa Journal of Threatened Taxa | www.threatenedtaxa.org | 10 April 2018 | 10(4): 11495–11550 Larval host plants of the butterflies of the Western Ghats, Monograph India Ravikanthachari Nitn 1, V.C. Balakrishnan 2, Paresh V. Churi 3,
    [Show full text]
  • That the Tout Untuk Ta on Mi Lova U It Aliana
    THATTHE TOUT UNTUK TAUS ON20170348276A1 MI LOVAU IT ALIANA (19 ) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2017/ 0348276 A1 Bryson et al . (43 ) Pub . Date : Dec . 7 , 2017 ( 54 ) NASAL CANNABIDIOL COMPOSITIONS A61K 47 /26 (2006 .01 ) A61K 47 / 02 (2006 .01 ) (71 ) Applicant: Acerus Pharmaceutical Corporation , A61K 36 / 185 ( 2006 .01 ) Mississauga (CA ) A61K 31 /05 ( 2006 .01 ) A61K 9 / 06 ( 2006 . 01 ) (72 ) Inventors : Nathan Bryson , Toronto (CA ) ; A61K 47 / 44 ( 2006 . 01) Avinash Chander Sharma, Brampton A61K 9 /00 (2006 . 01) (CA ) (52 ) U . S . CI. CPC .. .. .. A61K 31/ 352 (2013 . 01 ) ; A61K 47 /44 (21 ) Appl . No. : 15 /613 , 116 (2013 .01 ) ; A61K 47/ 38 ( 2013 .01 ) ; A61K 47/ 26 (2013 .01 ) ; A61K 9 / 0043 ( 2013 . 01 ) ; A61K ( 22 ) Filed : Jun . 2 , 2017 36 / 185 ( 2013 .01 ) ; A61K 31 /05 ( 2013 . 01 ) ; Related U . S . Application Data A61K 9 /06 (2013 . 01 ) ; A61K 47/ 02 (2013 . 01) (60 ) Provisional application No . 62 /426 ,403 , filed on Nov. (57 ) ABSTRACT 25 , 2016 , provisional application No. 62 /344 ,486 , A nasally administered cannabinoid semi- solid or viscous filed on Jun . 2 , 2016 . liquid composition ; nasal methods for administering the nasal pharmaceutical compositions ; methods for manufac Publication Classification turing the nasal pharmaceutical compositions ; and nasal ( 51 ) Int. Cl. methods of treating diseases treatable by the nasal pharma A61K 31/ 352 ( 2006 .01 ) ceutical compositions formulated with a cannabinoid or A61K 4738 ( 2006 .01 ) mixtures thereof. MULTIT - 134 . - . - - - - - - - - 130 - 102 132 c 100 me 144 N 128 140 - 150 120 - 124 Patent Application Publication Dec. 7 , 2017 Sheet 1 of 9 US 2017 / 0348276 A1 ? ??? ? .
    [Show full text]
  • Research Journal of Pharmaceutical, Biological and Chemical Sciences
    ISSN: 0975-8585 Research Journal of Pharmaceutical, Biological and Chemical Sciences In-silico Analysis, Homology Modelling And Docking Studies Of Essential Proteins Of Mycobacterium Leprae For Effective Treatment Of Leprosy. Sesha Charan Pasupuleti*. Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India. ABSTRACT The high emergence of multi-drug resistant strains of bacteria like Mycobacterium leprae caused the existing drugs to be ineffective against them. This impacted a need to quest novel targets and drug compounds to treat diseases like leprosy. Protein sequences of M.Leprae which are non-homologous to humans, participate in essential metabolic pathways of the bacteria and are necessary for the pathogen to survive were taken for study. Physiochemical characterisation, structural and functional analysis were carried out on these proteins. Their 3D structures were predicted were evaluated using various servers and workspaces. It was found that the proteins under study are acidic, thermostable and cytoplasmic in nature. Docking studies revealed that the herbal compounds which have least or no side effects were much more efficient than the chemical drugs. LysR family transcriptional regulator and MurE proteins of M.leprae were found to be the best targets to make novel drug formulations against the bacteria. Hops extract from Humuluslupulus, and Daucosterol from Justiciaadhatoda have maximum binding energies with the proteins under study. Thus the study showed that the herbal compounds interacted better with the proteins than the market drugs and were subjected to experimental evaluation to test their efficiency to treat leprosy. Keywords: Homology modelling, Molecular Docking, Leprosy, Mycobacterium Leprae, Herbal compounds, Drug discovery. *Corresponding author July–August 2018 RJPBCS 9(4) Page No.
    [Show full text]
  • WO 2017/208072 A2 07 December 2017 (07.12.2017) W ! P O PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/208072 A2 07 December 2017 (07.12.2017) W ! P O PCT (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, (21) International Application Number: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, PCT/IB2017/000759 DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (22) International Filing Date: HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, 02 June 2017 (02.06.2017) KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, (25) Filing Language: English PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, (26) Publication Language: English SD, SE, SG, SK, SL, SM, ST, SV, SY,TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 62/344,486 02 June 2016 (02.06.2016) US (84) Designated States (unless otherwise indicated, for every 62/426,403 25 November 2016 (25. 11.2016) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (71) Applicant: ACERUS PHARMACEUTICAL CORPO¬ UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, RATION [CA/CA]; 2486 Dunwin Drive, Mississauga, On TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, tario L5L 1J9 (CA).
    [Show full text]